GB9315595D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB9315595D0
GB9315595D0 GB939315595A GB9315595A GB9315595D0 GB 9315595 D0 GB9315595 D0 GB 9315595D0 GB 939315595 A GB939315595 A GB 939315595A GB 9315595 A GB9315595 A GB 9315595A GB 9315595 D0 GB9315595 D0 GB 9315595D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939315595A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RES INST MEDICINE CHEM
Research Institute for Medicine and Chemistry Inc
Original Assignee
RES INST MEDICINE CHEM
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RES INST MEDICINE CHEM, Research Institute for Medicine and Chemistry Inc filed Critical RES INST MEDICINE CHEM
Priority to GB939315595A priority Critical patent/GB9315595D0/en
Publication of GB9315595D0 publication Critical patent/GB9315595D0/en
Priority to PCT/GB1994/001631 priority patent/WO1995004046A1/en
Pending legal-status Critical Current

Links

GB939315595A 1993-07-28 1993-07-28 New compounds Pending GB9315595D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB939315595A GB9315595D0 (en) 1993-07-28 1993-07-28 New compounds
PCT/GB1994/001631 WO1995004046A1 (en) 1993-07-28 1994-07-28 Compounds as pde iv and tnf inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315595A GB9315595D0 (en) 1993-07-28 1993-07-28 New compounds

Publications (1)

Publication Number Publication Date
GB9315595D0 true GB9315595D0 (en) 1993-09-08

Family

ID=10739556

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939315595A Pending GB9315595D0 (en) 1993-07-28 1993-07-28 New compounds

Country Status (2)

Country Link
GB (1) GB9315595D0 (en)
WO (1) WO1995004046A1 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
US6245774B1 (en) * 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9507297D0 (en) * 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
DK0869945T3 (en) * 1995-06-07 2003-07-14 Pfizer Catechol dietary derivatives useful as pharmaceuticals
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
WO1998028281A1 (en) * 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
DK1212089T3 (en) 1999-08-21 2006-07-24 Altana Pharma Ag Synergistic combination of Roflumilast and Salmeterol
US7205320B2 (en) 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
KR100874791B1 (en) 2001-05-29 2008-12-18 바이엘 쉐링 파마 악티엔게젤샤프트 CDV-inhibited pyrimidine, preparation method thereof and use as medicament
MXPA05000827A (en) 2002-07-19 2005-08-29 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs.
CN100381425C (en) 2002-07-19 2008-04-16 记忆药物公司 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
AU2003263393A1 (en) * 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
AP2021A (en) 2002-10-23 2009-08-03 Glenmark Pharmaceuticals Ltd Novel tricyclic compounds useful for the treatmentof inflammatory and allergic disorders: Process f or their preparation and pharmaceutical compositions containing them
DE60334243D1 (en) * 2002-11-19 2010-10-28 Memory Pharmaceutical Corp PYRIDINE N-OXIDE COMPOUNDS ALSPHOSPHODIESTERASE-4-INHIBITORS
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA05008600A (en) 2003-02-13 2005-11-04 Wellstat Therapeutics Corp Compounds for the treatment of metabolic disorders.
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
CN1829711B (en) 2003-04-11 2010-06-16 格兰马克药品股份有限公司 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them
CA2583497A1 (en) 2004-10-13 2006-04-20 Glenmark Pharmaceuticals S.A. Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
KR101317119B1 (en) 2004-12-17 2013-10-11 그렌마크 파머수티칼스 에스. 아. Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
SI1831227T1 (en) 2004-12-17 2013-09-30 Glenmark Pharmaceuticals S.A. Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
ATE540675T1 (en) 2005-04-01 2012-01-15 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
JP2009531280A (en) 2006-01-25 2009-09-03 ウェルスタット セラピューティクス コーポレイション Compounds for treating metabolic disorders
JP2009524686A (en) 2006-01-25 2009-07-02 ウェルスタット セラピューティクス コーポレイション Compounds for treating metabolic disorders
JP2009525982A (en) 2006-02-02 2009-07-16 ウェルスタット セラピューティクス コーポレイション Compounds for the treatment of metabolic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2268141B1 (en) 2008-03-13 2019-05-08 Wellstat Therapeutics Corporation Compound and method for reducing uric acid
JP2011522828A (en) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
KR20160042039A (en) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 Compounds and methods for inhibiting phosphate transport
WO2016161268A1 (en) 2015-04-01 2016-10-06 Enanta Pharmaceuticals, Inc. Hepatitis b antviral agents
WO2016183266A1 (en) 2015-05-13 2016-11-17 Enanta Pharmaceuticals, Inc. Ehpatitis b antiviral agents
WO2017011552A1 (en) 2015-07-13 2017-01-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10301255B2 (en) * 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017136403A1 (en) 2016-02-02 2017-08-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
KR102398439B1 (en) 2016-03-07 2022-05-16 이난타 파마슈티칼스, 인코포레이티드 Hepatitis B antiviral drugs
US10189846B2 (en) 2016-06-10 2019-01-29 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
EP3675637A4 (en) 2017-08-28 2021-05-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2019113173A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2019113175A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US10729688B2 (en) 2018-03-29 2020-08-04 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
AU2019342750A1 (en) 2018-09-21 2021-04-08 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
AU2019385477A1 (en) 2018-11-21 2021-06-10 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
JP3333510B2 (en) * 1991-10-02 2002-10-15 スミスクライン・ビーチャム・コーポレイション Cyclopentane and cyclopentene derivatives having antiallergic, antiinflammatory and tumor necrosis factor inhibitory activities
DE69309030T2 (en) * 1992-06-15 1997-09-25 Celltech Therapeutics Ltd TRISUBSTITUTED PHENYL DERIVATIVES AS SELECTIVE PHOSPHODIESTERASE IV INHIBITORS

Also Published As

Publication number Publication date
WO1995004046A1 (en) 1995-02-09

Similar Documents

Publication Publication Date Title
GB9315595D0 (en) New compounds
GB9304620D0 (en) Compounds
GB9310978D0 (en) Compounds
GB9302016D0 (en) Compounds
GB9313144D0 (en) Compounds
GB9315801D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9317314D0 (en) Compounds
EP0733044A4 (en) Compounds
GB9302797D0 (en) New compounds
GB9320214D0 (en) Compounds
GB9300088D0 (en) Compounds
GB9302621D0 (en) Organiz compounds
GB9302636D0 (en) Compounds
GB9303808D0 (en) Compounds
GB9310425D0 (en) Compounds
GB9306431D0 (en) Compounds
GB9306432D0 (en) Compounds
GB9306433D0 (en) Compounds
GB9310459D0 (en) Compounds
GB9320617D0 (en) Compounds
GB9320616D0 (en) Compounds
GB9302027D0 (en) Compounds
GB9320186D0 (en) Compounds